Finance

Lists
DARE:NASDAQ
Dare Bioscience Inc
$0.68
+0.22%
(+0.0015) 1D
$0.65
-4.28% (-0.029)
After hours
Closed: Oct 29, 4:00:01β€―PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DARE...
Open
$0.67
High
$0.70
Low
$0.66
Mkt. cap
13.40M
Avg. vol.
185.43K
Volume
0.00
52-wk high
$3.78
52-wk low
$0.62
EPS
-$0.79
Beta
1.01
Shares outstanding
19.67M
No. of employees
21
Open
$0.67
High
$0.70
Low
$0.66
Mkt. cap
13.40M
Avg. vol.
185.43K
Volume
0.00
52-wk high
$3.78
52-wk low
$0.62
EPS
-$0.79
Beta
1.01
Shares outstanding
19.67M
No. of employees
21
News stories
From web sources and news partners
About Dare Bioscience Inc
CEOSabrina Martucci Johnson
Employees21
Founded2005
HeadquartersSan Diego, California, United States
SectorPharmaceutical industry
Websitedarebioscience.com
Analyst ratings
Based on 3 analysts giving stock ratings to DARE in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for DARE in the last 3 months.
Highest
Current $0.68
$12.00 (+1,660.82%)
Average
$7.33 (+975.57%)
Lowest
$2.00 (+193.47%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Initiated
$2.00
+193.5%
10/26/2026
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
$12.00
+1,660.8%
09/21/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$8.00
+1,073.9%
08/14/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.26K
1.02M
152.46K
187.55K
Cost of goods sold
1.18M
-4.61M
902.79K
561.86K
Cost of revenue
1.18M
-4.61M
902.79K
561.86K
Research and development expenses
-
5.52M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.50M
1.58M
2.25M
2.59M
Operating expense
2.50M
7.10M
2.25M
2.59M
Total operating expenses
3.67M
2.49M
3.15M
3.16M
Operating income
-3.67M
-1.47M
-3.00M
-2.97M
Other non operating income
109.38K
29.55K
-991.00
-14.79K
EBT including unusual items
-3.56M
-1.44M
-3.00M
-2.98M
EBT excluding unusual items
-3.56M
-1.44M
-3.00M
-2.98M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.56M
-1.44M
-3.00M
-2.98M
Net profit margin
-157,505.13%
-140.84%
-1,967.72%
-1,590.42%
Earnings per share
-0.28
-0.10
-0.20
-0.20
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.19M
-936.87K
-2.44M
-2.40M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps